Summary
Lidoflazine, a new and very longacting coronary vasodilator was given to 18 dogs with a chronically developing stenosis and occlusion of the circumflex coronary artery for 4 and 6 weeks respectively. 18 other dogs with chronically developing stenoses leading to occlusion of the circumflex artery were used as controls. Lidoflazine in a dosis of 20 mg/kg/day increased the speed of development of the collateral circulation and prohibited symptoms of permanent cardiac hypoxia. Permanent myocardial hypoxia, caused by a higher degree of physical activity in a group of “freely exercising” dogs produced the same favorable effects on the canine coronary collateral circulation.
Similar content being viewed by others
References
Litvak, J., L. E. Siderides, and A. M. Vineberg: The experimental production of coronary artery insufficiency and occlusion. Amer. Heart J. 53, 505 (1957).
Schaper, W. K. A., A. H. M. Jageneau, and J. M. Bogaard: Hemodynamic and respiratory responses to dehydrobenzperidol, a potent neuroleptic compound in intact anesthetized dogs. Drug Res. 13, 316 (1963).
-- -- and solR. Xhonneux: The pharmacology of lidoflazine (R 7904), a new longacting coronary vasodilator. (In preparation.)
Wetterer, E., u. H. P. Pieper: Über die Gesamtelastizität des arteriellen Windkessels und ein experimentelles Verfahren zu ihrer Bestimmung am lebenden Tier. Z. Biol. 106, 23 (1953).
Yelnosky, J., and J. F. Gardocki: A study of some of the pharmacological actions of fentanyl citrate and droperidol. Toxicol. appl. Pharmacol. 6, 63 (1964).
Author information
Authors and Affiliations
Additional information
With 6 Figures in the Text
Rights and permissions
About this article
Cite this article
Schaper, W.K.A., Xhonneux, R. & Jageneau, A.H.M. Stimulation of the coronary collateral circulation by lidoflazine (R 7904). Naunyn - Schmiedebergs Arch 252, 1–8 (1965). https://doi.org/10.1007/BF00246424
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00246424